TRIM22 actives PI3K/Akt/mTOR pathway to promote psoriasis through enhancing cell proliferation and inflammation and inhibiting autophagy

References

• Griffiths CEM, Armstrong AW, Gudjonsson JE, et al. Psoriasis. Lancet 2021;397:1301–1315.
   PubMed Web of Science ®Google Scholar
• Rendon A, Schakel K. Psoriasis pathogenesis and treatment. Int J Mol Sci 2019;20. doi:10.3390/ijms20061475
   Web of Science ®Google Scholar
• Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007;370:263–271.
   PubMed Web of Science ®Google Scholar
• Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005;64:ii18–23.
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 2020;323:1945–1960.
   PubMed Web of Science ®Google Scholar
• Liu T, Duan X, He J, et al. KCNQ1OT1 promotes the proliferation and migration of psoriatic keratinocytes by regulating miR-183-3p/GAB1. Allergol Immunopathol (Madr) 2021;49:125–130.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhou H, Zheng H, et al. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin in flammation. Autophagy 2021;17:529–552.
   PubMed Web of Science ®Google Scholar
• Hailfinger S, Schulze-Osthoff K. Impaired autophagy in psoriasis and atopic dermatitis: a new therapeutic target? J Invest Dermatol 2021;141:2775–2777.
   PubMed Web of Science ®Google Scholar
• Yang L, Jin L, Ke Y, et al. E3 ligase Trim21 ubiquitylates and stabilizes keratin 17 to induce STAT3 activation in psoriasis. J Invest Dermatol 2018;138:2568–2577.
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang T, Zhang C, et al. Upregulated E3 ligase tripartite motif-containing protein 21 in psoriatic epidermis ubiquitylates nuclear factor-kappaB p65 subunit and promotes inflammation in keratinocytes. Br J Dermatol 2021;184:111–122.
   PubMed Web of Science ®Google Scholar
• Liu Y, Lagowski JP, Gao S, et al. Regulation of the psoriatic chemokine CCL20 by E3 ligases Trim32 and Piasy in keratinocytes. J Invest Dermatol 2010;130:1384–1390.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhou XM, Yang FF, et al. TRIM22 confers poor prognosis and promotes epithelial-mesenchymal transition through regulation of AKT/GSK3beta/beta-catenin signaling in non-small cell lung cancer. Oncotarget 2017;8:62069–62080.
   PubMedGoogle Scholar
• Ji J, Ding K, Luo T, et al. TRIM22 activates NF-kappaB signaling in glioblastoma by accelerating the degradation of IkappaBalpha. Cell Death Differ 2021;28:367–381.
   PubMed Web of Science ®Google Scholar
• Kang C, Lu Z, Zhu G, et al. Knockdown of TRIM22 relieves oxygen-glucose deprivation/reoxygenation-induced apoptosis and inflammation through inhibition of NF-kappaB/NLRP3 Axis. Cell Mol Neurobiol 2021;41:341–351.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen Y, Lin Y, et al. TRIM22 inhibits respiratory syncytial virus replication by targeting JAK-STAT1/2 signaling. J Med Virol 2021;93:3412–3419.
   PubMed Web of Science ®Google Scholar
• Raposo RA, Gupta R, Abdel-Mohsen M, et al. Antiviral gene expression in psoriasis. J Eur Acad Dermatol Venereol 2015;29:1951–1957.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liang HX, Zhang CM, et al. FOXO3/TRIM22 axis abated the antitumor effect of gemcitabine in non-small cell lung cancer via autophagy induction. Transl Cancer Res 2020;9:937–948.
   PubMed Web of Science ®Google Scholar
• Luan Y, Ren KD, Luan Y, et al. Mitochondrial dynamics: pathogenesis and therapeutic targets of vascular diseases. Front Cardiovasc Med 2021;8:770574.
   PubMed Web of Science ®Google Scholar
• Medrano LM, Rallon N, Berenguer J, et al. Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients. J Transl Med 2016;14:257.
   PubMed Web of Science ®Google Scholar
• Li Q, Lee CH, Peters LA, et al. Variants in TRIM22 that affect NOD2 signaling are associated with very-early-onset inflammatory bowel disease. Gastroenterology 2016;150:1196–1207.
   PubMed Web of Science ®Google Scholar
• Lou J, Wang Y, Zheng X, et al. TRIM22 regulates macrophage autophagy and enhances Mycobacterium tuberculosis clearance by targeting the nuclear factor-multiplicity kappaB/beclin 1 pathway. J Cell Biochem 2018;119:8971–8980.
   PubMed Web of Science ®Google Scholar
• Yang X, Niu L, Pan Y, et al. LL-37-induced autophagy contributed to the elimination of live Porphyromonas gingivalis internalized in keratinocytes. Front Cell Infect Microbiol 2020;10:561761.
   PubMed Web of Science ®Google Scholar
• Xie X, Zhang L, Li X, et al. Liangxue Jiedu formula improves psoriasis and dyslipidemia comorbidity via PI3K/Akt/mTOR pathway. Front Pharmacol 2021;12:591608.
   PubMed Web of Science ®Google Scholar
• Yue L, Ailin W, Jinwei Z, et al. PSORI-CM02 ameliorates psoriasis in vivo and in vitro by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway. Phytomedicine 2019;64:153054.
   PubMed Web of Science ®Google Scholar
• Choi SK, Hong YO, Lee WM, et al. Overexpression of PI3K-p110alpha in the progression of uterine cervical neoplasia and its correlation with pAkt and DJ-1. Eur J Gynaecol Oncol 2015;36:389–393.
   PubMed Web of Science ®Google Scholar
• Yang Y, Luan Y, Feng Q, et al. Epigenetics and beyond: targeting histone methylation to treat type 2 diabetes mellitus. Front Pharmacol 2021;12:807413.
   PubMed Web of Science ®Google Scholar
• Varshney P, Saini N. PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis. Biochim Biophys Acta Mol Basis Dis 2018;1864:1795–1803.
   PubMed Web of Science ®Google Scholar
• Li L, Qi Y, Ma X, et al. TRIM22 knockdown suppresses chronic myeloid leukemia via inhibiting PI3K/Akt/mTOR signaling pathway. Cell Biol Int 2018;42:1192–1199.
   PubMed Web of Science ®Google Scholar